Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
12/2010
12/01/2010EP2255828A1 Methods of therapy for cancers expressing the CD40 antigen
12/01/2010EP2255823A1 Intestinal immune system stimulator
12/01/2010EP2255818A1 Oral or enteral composition useful for recovery of physical functions
12/01/2010EP2255801A1 Pharmaceutically active isoindoline derivatives
12/01/2010EP2255800A1 Arsenic trioxide for use in the treatment of leukaemia
12/01/2010EP2255799A1 Agent for combating the side effects of cancer chemotherapy
12/01/2010EP2255194A1 Methods for prognosing the status of tumor patients
12/01/2010EP2254901A1 Therapeutic peptides
12/01/2010EP2254888A1 Novel aminopyridine derivatives having aurora a selective inhibitory action
12/01/2010EP2254885A1 (pyrazolyl carbonyl)imidazolidinone derivatives for the treatment of retroviral diseases
12/01/2010EP2254882A2 Intermediates and a process employing the intermediates for the preparation of (3-trifluoromethylsulfonyl)-n-[4-methyl-3- (4-pyridin-3-yl-pyrimidin-2ylamino)-phenyl]-benzamide
12/01/2010EP2254862A2 Azetidine-derived compounds, preparation method therefor and therapeutic use of same
12/01/2010EP2254668A2 Microrna signatures associated with human chronic lymphocytic leukemia (ccl) and uses thereof
12/01/2010EP2254667A2 Treatment of diseases and conditions mediated by eicosanoids
12/01/2010EP2254603A2 Methods for inhibiting six 1 and eya proteins
12/01/2010EP2254602A2 Continuous cell programming devices
12/01/2010EP2254583A1 Anticancer agent
12/01/2010EP2254573A1 Compositions comprising phytoestrogens selective for estrogen beta receptor and dietary fibres
12/01/2010EP2254571A2 Combinations of an anti-her2 antibody-drug conjugate and chemotherapeutic agents, and methods of use
12/01/2010EP2254570A1 Combination comprising paclitaxel for treating ovarian cancer
12/01/2010EP2254566A2 Kinase protein binding inhibitors
12/01/2010EP2254557A1 Methods to inhibit tumor cell growth by using proton pump inhibitors
12/01/2010EP1904494B1 Imidazo[1,2-a]pyridine compounds as vegf-r2 inhibitors
12/01/2010EP1869020B1 Heteroaryl urea derivatives useful for inhibiting chk1
12/01/2010EP1806141B1 Par-2 antagonists
12/01/2010EP1449850B1 Human cdr-grafted antibodies and antibody fragments thereof
12/01/2010EP1427441B1 COMPOSITE SUPERIMMUNOGEN FOR BI-FUNCTIONAL VACCINE Tat-gp160 FOR USE IN THE TREATMENT OF AIDS
12/01/2010EP1423425B1 Receptor, the use thereof, and mouse antibodies
12/01/2010EP1244790B1 Nucleic acids encoding polypeptides having chips activity
12/01/2010EP1137441B1 Ion exchange tumor targeting (iett)
12/01/2010CN1993353B Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase
12/01/2010CN1951495B Nano target medicine for magnetothermal therapy of malignant tumor
12/01/2010CN1727362B Preparation and application of vaccine for curing tumor in positive carcino-embryonic antigen
12/01/2010CN1694715B Use of beta glucan particles and antibodies in preparing medicine for cancer therapy
12/01/2010CN1646154B Albumin-fused anti-angiogenesis peptides
12/01/2010CN101903403A CD19 binding agents and uses thereof
12/01/2010CN101903402A Humanized antibodies against TL1A
12/01/2010CN101903396A Novel modulators of cell cycle checkpoints and their use in combination with checkpoint kinase inhibitors
12/01/2010CN101903395A Compounds for inhibiting KSP kinesin activity
12/01/2010CN101903389A Pharmaceutically acceptable salts of methyl (3-{ [[3-(6- amino- 2-butoxy-8-oxo-7, 8-dihydro-9h-purin-9-yl) propyl] (3- morpholin-4-ylpropyl) amino] methyl }phenyl) acetate and their use in therapy
12/01/2010CN101903388A Spiroindolinone derivatives as anticancer agents
12/01/2010CN101903387A 8-anilin0imidaz0pyridines and their use as anti-cancer and/or anti-inflammatory agents
12/01/2010CN101903384A [1h-pyrazolo [3, 4-b] pyridine-4-yl]-phenyle or -pyridin-2-yle derivatives as protein kinase C-theta
12/01/2010CN101903374A 2-benzylpyridazinone derivatives as met kinase inhibitors
12/01/2010CN101903365A Spiro-condensed 1, 3, 4-thiadiazole derivatives for inhibiting KSP kinesin activity
12/01/2010CN101903357A Cyclic amine substituted pyrimidinediamines as PKC inhibitors
12/01/2010CN101903349A 4-(4-pyridinyl)-benzamides and their use as ROCK activity modulators
12/01/2010CN101903343A Compounds for inhibiting KSP kinesin activity
12/01/2010CN101903046A Constructs containing multiple expression cassettes for cancer therapy
12/01/2010CN101903034A Method for increasing the therapeutic efficacy of curcuminoids and analogues
12/01/2010CN101903029A Combination therapy with organic arsenicals
12/01/2010CN101903028A Medium-chain length fatty acids, salts and triglycerides in combination with gemcitabine for treatment of pancreatic cancer
12/01/2010CN101899471A Recombinant retrovirus vector for simultaneously expressing antigen-specific receptor and exogenous gene, B-lymphocyte modified by using same and application thereof
12/01/2010CN101899465A Recombinant J subgroup avian leucosis virus infective cloned plasmids and preparation method and application thereof
12/01/2010CN101899443A Method for regulating and controlling FAF1 (Fas-associated Factor-1) genes, composition and application thereof
12/01/2010CN101899295A Organic polymeric photon up-conversion nanoparticles for biological applications
12/01/2010CN101899117A Streptavidin/interleukin 21 fusion protein
12/01/2010CN101899114A Antibodies against PD-1 and uses therefor
12/01/2010CN101899104A Low molecular weight peptide of shark cartilage angiogenesis inhibiting factor, production purifying method and application thereof
12/01/2010CN101899099A X4 peptide synthetic product and application thereof
12/01/2010CN101899097A Blood group B epitope mimic peptide and application thereof
12/01/2010CN101899096A Blood group A epitope mimic peptide and application thereof
12/01/2010CN101899095A Centipede toxin anti-tumour active polypeptide
12/01/2010CN101899093A X2 polypeptide synthesis product and application thereof.
12/01/2010CN101899082A Triterpenoid saponin compound, application and preparation method
12/01/2010CN101899075A Beta-N-glucosylated-alpha-aminophosphonate compound
12/01/2010CN101899073A B Methyl-5-deoxidation-(dialkyl phosphate)-5-(dialkyl phosphamide)-2, 3-O-propylidene-belta-D-furanoside-contained compound
12/01/2010CN101899057A Preparation method of pyrimido-oxazole derivative and use thereof in medicine
12/01/2010CN101899053A C crystal form solid matter of bergenin and preparation method and application thereof
12/01/2010CN101899052A B-crystal form solid matter of bergenin and preparation method and application thereof
12/01/2010CN101899051A 1-azaxanthone-3-formamide compounds as well as preparation method and antitumor application thereof
12/01/2010CN101899049A Disubstituted pyrazolobenzodiazepines
12/01/2010CN101899047A Beta-amino tetrahydropyrazine, tetrahydropyrimidine and tetrahydropyridine used as dipeptidy peptidase inhibitors for curing or preventing diabetes
12/01/2010CN101899043A Tylophora ovata base analogs with anti-tumor activity and preparation method and use thereof
12/01/2010CN101899039A Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist
12/01/2010CN101899011A Dithiocarbamates compound, preparation method and application thereof
12/01/2010CN101899008A N-substituted pyrimidine sulfonyl-substituted benzamide type small molecular inhibitor for Bcl-2 protein and application thereof
12/01/2010CN101899001A N-(2-amino-4-pyridyl)-benzamide derivative and application thereof
12/01/2010CN101898985A N-substituted benzenesulfonyl-substituted benzamides small molecular inhibitor of Bcl-2 protein and application thereof
12/01/2010CN101898979A Phenyl nitrone compounds containing stilbene sections and application thereof
12/01/2010CN101898978A Eflornithine prodrug and conjugate and using method thereof
12/01/2010CN101898962A Rhein crystal B-type solid matter, preparation method and use
12/01/2010CN101898961A Parietic acid crystal C type solid matter as well as preparation method and application thereof
12/01/2010CN101898960A Rheinic acid crystal type A solid substance and preparation method and application thereof
12/01/2010CN101898936A Novel antitumor terpenoid FW03105
12/01/2010CN101897983A Monocyte-specific particulate delivery vehicle
12/01/2010CN101897982A SiRNA medicinal composition for treating cancers
12/01/2010CN101897981A Method for inhibiting proliferation and inducing apoptosis of cancer cells and use thereof
12/01/2010CN101897979A Targeted medicament for curing prostate diseases
12/01/2010CN101897955A Cell factor composition for immune regulation
12/01/2010CN101897953A Non-invasive high-penetrability epidermal growth factor and application thereof
12/01/2010CN101897908A Traditional Chinese medicine composition for treating cirrhosis ascites and liver cancer and preparation method thereof
12/01/2010CN101897892A Method for preparing injection of traditional Chinese medicine glabrous sarcandra herb
12/01/2010CN101897891A Chinese medicinal powder for treating cecidium
12/01/2010CN101897873A Preparation method of Xiaojiean extract
12/01/2010CN101897869A Medicament for treating tumor
12/01/2010CN101897860A Chinese patent medicament oral pills for treating tumors
12/01/2010CN101897855A Medicament for treating uterine myoma
12/01/2010CN101897846A Subsiding swelling soup for mastocarcinoma
12/01/2010CN101897839A Comprehensive utilization method of banana stalks
1 ... 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 ... 2211